Endoscopic colorectal cancer surveillance in inflammatory bowel disease: Considerations that we must not forget |
| |
Authors: | Paulina Núez F Rodrigo Quera David T Rubin |
| |
Institution: | Universidad de los Andes, Digestive Disease Center, Inflammatory Bowel Disease Program, Clinica, Santiago 7620157, RM, Chile;Department of Gastroenterology, Hospital San Juan de Dios. Universidad de Chile, Santiago 7701230, RM, Chile;Medicine Inflammatory Bowel Disease Center, University of Chicago, Chicago, IL 60637, United States. ude.ogacihcu.dsb.enicidem@niburd |
| |
Abstract: | Inflammatory bowel disease (IBD), encompassing Crohn''s disease and ulcerative colitis, is a chronic immune-mediated inflammatory disease that primarily affects the gastrointestinal tract and is characterized by periods of activity and remission. The inflammatory activity of the disease involving the colon and rectum increases the risk of colorectal cancer (CRC) over the years. Although prevention strategies are evolving, regular surveillance for early detection of neoplasia as a secondary prevention strategy is paramount in the care of IBD patients. In this review article, we discuss the current evidence of the risks of developing CRC and evaluate the best available strategies for screening and surveillance, as well as future opportunities for cancer prevention. |
| |
Keywords: | Inflammatory bowel disease Endoscopy Crohn’ s disease Ulcerative colitis Surveillance Colorectal cancer |
|
|